Aleksandr Pankov
PhD
ORIC Pharmaceuticals
Appearances
ORIC-944, a Potent and Selective Allosteric PRC2 Inhibitor, Mediates Antitumor Efficacy Through Distinct Mechanisms in Two Prostate Cancer Xenograft Models